Wolverine Trading’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,900
Closed -$284K 5214
2024
Q3
$284K Buy
+12,900
New +$276K ﹤0.01% 3691
2024
Q1
Sell
-11,700
Closed -$369K 4457
2023
Q4
$369K Buy
11,700
+3,300
+39% +$78.4K ﹤0.01% 3263
2023
Q3
$215K Buy
+8,400
New +$259K ﹤0.01% 3680
2022
Q2
Sell
-16,700
Closed -$460K 4447
2022
Q1
$460K Sell
16,700
-5,100
-23% -$130K ﹤0.01% 3339
2021
Q4
$848K Buy
+21,800
New +$888K ﹤0.01% 2814
2021
Q2
Sell
-26,900
Closed -$1.04M 5876
2021
Q1
$1.04M Sell
26,900
-27,400
-50% -$1.63M ﹤0.01% 2705
2020
Q4
$2.54M Buy
54,300
+31,300
+136% +$2.12M ﹤0.01% 1512
2020
Q3
$983K Buy
23,000
+1,300
+6% +$64.5K ﹤0.01% 2105
2020
Q2
$1.02M Buy
+21,700
New +$748K ﹤0.01% 1979
2020
Q1
Sell
-13,000
Closed -$135K 4578
2019
Q4
$135K Buy
+13,000
New +$136K ﹤0.01% 4190
2016
Q4
Sell
-7,657
Closed -$135K 4408
2016
Q3
$135K Sell
7,657
-72
-0.9% -$2.33K ﹤0.01% 4058
2016
Q2
$235K Buy
+7,729
New +$244K ﹤0.01% 3087

Other funds holding ARCT